How can a diabetologist help a patient after ischemic stroke?

Česká verzia

Authors: Jan Brož ¹; Jana Malinovská ¹; Barbora Pelechová ¹; Jana Urbanová ²; Ludmila Brunerová ²
Authors place of work: Interní klinika FN Motol a 2. LF UK, Praha ¹; Interní klinika 3. LF UK a FNKV, Praha ²
Published in the journal: Vnitř Lék 2021; 67(E-3): 33-34
Category:

Komentář k článku Co může internista udělat pro svého pacienta po ischemické cévní mozkové příhodě Vnitř Lek 2021; 67(1): 7–14

Zdroje

1. Škorňa M. Co může internista udělat pro svého pacienta po iCMP? Vnitr Lek 2021; 67(1): 7–14.

2. Emerging Risk Factors Collaboration: Sarwar N, Gao P, Seshasai SR et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta- analysis of 102 prospective studies. Lancet 2010; 375: 2215–2222.

3. Khoury JC, Kleindorfer D, Alwell K et al. Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke. 2013; 44(6): 1500–1504.

4. Reeves MJ, Vaidya RS, Fonarow GC, Liang L, Smith EE, Matulonis R, Olson DM, Schwamm LH; Get With The Guidelines Steering Committee and Hospitals: Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines-Stroke. Stroke 2010; 41: e409–e417.

5. Newman GC, Bang H, Hussain SI, Toole JF: Association of diabetes, homocysteine, and HDL with cognition and disability after stroke. Neurology 2007; 69: 2054–2062.

6. Kernan WN, Viscoli CM, Furie KL et al.; IRIS Trial Investigators: Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med; 374: 1321–1331.

7. Antithrombotic Trialists’ Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86.

8. Diabetes and Stroke. In: Cowie CC, Casagrande SS, Menke A, et al., Diabetes in America. Bethesda, 2018, 3rd edition.

9. Doporučení pro diagnostiku a léčbu arteriální hypertenze České společnosti pro hypertenzi 2017. [cit. 2021–04–03]. Dostupné z WWW: http://www.hypertension.cz/sqlcache/ widimsky-1-hypertenze-kv-prevence-2018.pdf.

10. Česká společnost pro aterosklerózu. Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019. [cit. 2021–04–03]. Dostupné z WWW: https://www.cskb.cz/wp-content/uploads/2019/12/Stanovisko- v%C3%BDboru-%C4%8Cesk%C3%A9-spole%C4%8Dnosti-pro-ateroskler%C3%B- 3zu-k-doporu%C4%8Den%C3%ADm-ESC_EAS-pro-diagnostiku-a-l%C3%A9%C4%8Dbu- -dyslipidemi%C3%AD-z-roku-2019.pdf

11. Task Force Members. 2019 European Society of Cardiology guidelines on diabetes, pre-diabetes,and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal 2020; 41, 255323.

12. David S.H. Bell, Edison Goncalves. Stroke in the patient with diabetes (Part 2) – Prevention and the effects of glucose lowering therapies. Diabetes Research and Clinical Practice 2020; 164,108199.